IDEXX Laboratories Inc. ($IDXX) Stock Forecast: Down 5.6% Today

What is IDEXX Laboratories Inc.?

IDEXX Laboratories (NASDAQ: IDXX) is a company that specializes in developing diagnostic and software products for veterinary, livestock, and poultry markets. The stock had a strong bearish movement today amidst recent news and market activity.

Why is IDEXX Laboratories Inc. going down?

IDXX stock is down 5.6% on Aug 5, 2025 15:10

• IDEXX Laboratories (IDXX) stock experienced a bearish movement despite surpassing earnings expectations and posting strong Q2 results.
• The market may have reacted negatively due to profit-taking by investors after a period of growth following the positive earnings report.
• Despite the positive news of revenue growth, EPS beat, and raised guidance, the stock might have been impacted by broader market trends or sector rotation.
• Investors might be cautious about the stock's valuation or potential future challenges despite the company's strong performance.

IDXX Price Chart

IDXX Technical Analysis

IDXX News

Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades' - IDEXX Laboratories ( NASDAQ:IDXX ) , Delta Air Lines ( NYSE:DAL )

Jim Lebenthal names Delta Air Lines as his final trade. Bryn Talkington recommends sticking with Tesla. The next correction is closer than you think. Find out how Tom Gentile plans to trade it, live on Wednesday.

https://www.benzinga.com/trading-ideas/long-ideas/25/08/46855508/tesla-delta-air-idexx-laboratories-and-more-on-cnbcs-final-trades

Here's How Much $1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 4.25% on an annualized basis producing an average annual return of 12.73%. Currently, IDEXX Laboratories has a market capitalization of $55.35 billion.

https://www.benzinga.com/insights/news/25/08/46832845/heres-how-much-1000-invested-in-idexx-laboratories-20-years-ago-would-be-worth-today

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation - IDEXX Laboratories ( NASDAQ:IDXX )

IDEXX Q2 earnings of $3.50 beat estimates; revenue rose 11% to $1.11 billion, driven by 11% growth in Companion Animal Group sales. Full-year EPS guidance raised to $12.40-$12.76 vs. $12.13 consensus; revenue forecast increased to $4.21-$4.28 billion.

https://www.benzinga.com/markets/earnings/25/08/46829645/idexx-surpasses-earnings-expectations-justifying-premium-valuation

IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand

IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.

https://www.zacks.com/stock/news/2662169/idexx-stock-up-on-q2-earnings-revenue-beat-margins-expand

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.2% Today

XRP ($XRP) Crypto Forecast: Down 5.1% Today

Cardano ($ADA) Crypto Forecast: Down 5.1% Today

Chainlink ($LINK) Crypto Forecast: Down 5.4% Today

Lithia Motors Inc. ($LAD) Stock Forecast: Up 5.1% Today

ONEOK Inc. ($OKE) Stock Forecast: Down 5.0% Today

Transdigm Group Incorporated Inc. ($TDG) Stock Forecast: Down 12.7% Today

Eaton Corporation PLC ($ETN) Stock Forecast: Down 6.7% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 7.2% Today

Pfizer Inc. ($PFE) Stock Forecast: Up 5.0% Today

IDEXX Laboratories Inc. Price History

21.07.2024 - IDXX Stock was down 0.6%

• The downward trend in IDXX today may be due to the following reasons:
• Profit-taking: Investors who have realized substantial profits from holding IDXX stock for an extended period may have opted to sell shares to secure their gains, resulting in a decrease in the stock price.
• Market correction: Following a period of sustained success, IDXX might be undergoing a natural market correction as investors review their positions and explore new investment prospects.
• External influences: Economic conditions or industry-related developments could also be impacting the bearish movement in IDXX today, prompting investors to modify their investment portfolios accordingly.

30.00.2025 - IDXX Stock was up 5.2%

• IDXX's upturn today is linked to market expectations of robust Q4 earnings, attributed to the company's successful execution of strategic initiatives.
• Investors are positive about IDXX's outlook, anticipating growth and profitability in the upcoming period.
• The favorable outlook for IDXX mirrors the market's confidence in the company's capability to deliver value and sustain a competitive position in the veterinary diagnostics sector.

31.09.2024 - IDXX Stock was down 9.5%

• Third-quarter earnings of IDXX surpassed adjusted EPS predictions but fell short of revenue consensus, hinting at possible hurdles in revenue expansion.
• The deceleration in revenue growth is possibly linked to a decline in veterinary visits, influencing the company's sales trajectory.
• Noteworthy growth in segments such as CAG and Water was eclipsed by the lower-than-expected revenue, possibly instigating a downward trend in the stock's value.
• Concerns among investors about IDXX's future growth sustainability are palpable, with guidance adjustments contributing to the stock's market decline.

01.04.2025 - IDXX Stock was up 9.0%

• IDEXX Laboratories has showcased an average annual return of 21.28% over the past 10 years.
• The company boasts a market capitalization of $35.41 billion, indicating its market strength and resilience.
• Today, IDXX experienced a bullish movement likely attributed to its consistent growth and robust financial performance that has attracted investors seeking high returns.

01.04.2025 - IDXX Stock was up 9.0%

• Strong Q1 earnings were reported by IDXX, surpassing expectations and resulting in an increased outlook for the fiscal year 2025. This positive financial performance has led to heightened investor interest and a rise in the stock price.
• Over the past decade, IDXX has consistently outperformed the market, achieving an impressive annualized return of 21.28%. This track record has likely fostered investor confidence in the company's future growth prospects.
• The notable financial results and a history of market-beating returns have fueled a positive trend in IDXX stock, reflecting optimistic investor attitudes and confidence in the company's future prospects.

04.07.2025 - IDXX Stock was up 4.2%

• IDEXX reported strong Q2 earnings, surpassing expectations with earnings of $3.50 per share and revenue reaching $1.11 billion.
• The impressive 11% growth in Companion Animal Group sales contributed to the revenue increase, showcasing the company's strong performance in its core business segment.
• The raised full-year EPS guidance and revenue forecast indicate a positive outlook for IDEXX, reassuring investors and justifying the premium valuation of the stock.
• Overall, the market responded positively to IDEXX's robust financial results and optimistic future prospects, driving the stock price higher.

15.04.2024 - IDXX Stock was up 5.2%

• Upgrading IDXX from a hold to a buy rating likely boosted investor confidence in the company's future prospects, leading to increased buying activity.
• The announcement of IDEXX Laboratories' participation in the Stifel Jaws & Paws Conference and the 2024 Investor Day could have signaled to investors the company's commitment to innovation and growth, further driving up the stock price.
• The leadership transition and shareholder approval news may have instilled confidence in investors regarding the company's strategic direction and stability, contributing to the bullish movement in the stock.
• Overall, the combination of positive news catalysts, such as upgrades, conference participation, and leadership transitions, likely fueled the strong bullish movement in IDXX's stock price today.

31.06.2025 - IDXX Stock was down 5.1%

• Despite high expectations for Q2 earnings with anticipated growth in various segments, IDXX experienced a strong bearish movement today.
• The market may have reacted negatively to the actual earnings release, which potentially fell short of the optimistic forecasts.
• Investors might have been disappointed by certain aspects of the earnings report, such as lower-than-expected revenue or guidance for future performance.
• It's possible that profit-taking or market dynamics unrelated to the company's fundamentals also contributed to the bearish movement in IDXX's stock price today.

17.06.2024 - IDXX Stock was up 5.1%

• The bullish movement in IDXX stock today could be attributed to the positive P/E ratio insights, indicating potential undervaluation and attracting investors.
• The comparison with another stock might have highlighted IDXX as a more favorable option, driving increased buying interest.
• Despite the downgrade to a "Hold" rating, investors may have interpreted this as a neutral stance rather than a negative one, leading to a continued bullish sentiment in the market.
• Overall, the combination of positive valuation metrics, comparative analysis, and the perceived neutral rating change likely contributed to the strong bullish movement in IDXX stock today.

05.07.2025 - IDXX Stock was down 5.6%

• IDEXX Laboratories (IDXX) stock experienced a bearish movement despite surpassing earnings expectations and posting strong Q2 results.
• The market may have reacted negatively due to profit-taking by investors after a period of growth following the positive earnings report.
• Despite the positive news of revenue growth, EPS beat, and raised guidance, the stock might have been impacted by broader market trends or sector rotation.
• Investors might be cautious about the stock's valuation or potential future challenges despite the company's strong performance.

06.07.2024 - IDXX Stock was up 5.3%

• Following the impressive second-quarter results, IDXX stock demonstrated a bullish trend, surpassing estimates for both EPS and revenue.
• The favorable earnings report, highlighted by exceeding EPS forecasts and revenue growth, likely enhanced investor confidence in the company's performance and future outlook.
• Despite lowering its FY24 guidance in a separate update, the market primarily responded to the strong quarterly results, propelling a bullish sentiment in IDXX stock.
• The failure to meet earnings and revenue projections in a different statement did not notably sway market sentiment towards IDXX today, as attention remained focused on the positive quarterly showing.

06.07.2024 - IDXX Stock was up 5.8%

• Despite reducing its FY24 guidance and falling short of earnings projections, the robust revenue growth in the second quarter, notably in CAG and Water divisions, likely made a positive impression on investors.
• The rescheduled earnings call possibly hinted at favorable developments or strategic changes within the company, prompting optimism among investors.
• The market's positive response may suggest that investors are placing more emphasis on the company's future growth prospects and innovative solutions rather than immediate financial setbacks.